Under the leadership of Stéphane AMINE, founder of Inovalis and a pioneer in closed-end real estate investment funds in Europe, ICORP-MED was created in 2015 by a team of passionate healthcare professionals.Since, the company has been dedicated to building the healthcare landscape of tomorrow by improving access to highly qualitative health care through significant medical advancements for all. Due to its rapid growth, the holding company welcomed Dani ABI CHALA as Executive Director in September 2024 to accelerate its development.
ICORP-MED focuses on the research and development of advanced healthcare technologies, leveraging innovative approaches to address some of the most pressing health challenges :
Cardiovascular health – Axelife
Access to care – HelloCare
Enhancing quality of life – Delled & BioLeaf
ICORP-MED conveys its vision and expertise through its Medtech subsidiaries, with research and innovation at the core of its DNA.
Company Details
- Employees
- 9
- Founded
- -
- Address
- 52, Rue De Bassano, Paris,île-De-France 75008,france
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Keywords
- de la prévention cardiovasculaire !.
- HQ
- Paris, Île-de-France
Icorp-Med Questions
Icorp-Med's LinkedIn profile is https://fr.linkedin.com/company/icorp-med
Icorp-Med has
9 employees.
View email and phone details for 9
employees at Icorp-Med.
Icorp-Med's industry is
Venture Capital and Private Equity Principals
Icorp-Med's top competitors are
Bio Leaf Health Lda,
Future4care,
Advenis,
Inovalis Real Estate Funds Manager,
Axelife,
Hellocare,
Ares Conseil France,
Lexzur,
Delled - Lafleur,
Axium Assurance.
Icorp-Med's categories are Venture Capital and Private Equity Principals
Icorp-Med's founding year is 2015
